vs
Side-by-side financial comparison of DOMO, INC. (DOMO) and Xeris Biopharma Holdings, Inc. (XERS). Click either name above to swap in a different company.
Xeris Biopharma Holdings, Inc. is the larger business by last-quarter revenue ($85.8M vs $79.4M, roughly 1.1× DOMO, INC.). Xeris Biopharma Holdings, Inc. runs the higher net margin — 12.9% vs -13.1%, a 26.0% gap on every dollar of revenue. On growth, Xeris Biopharma Holdings, Inc. posted the faster year-over-year revenue change (42.8% vs -0.5%). Over the past eight quarters, Xeris Biopharma Holdings, Inc.'s revenue compounded faster (45.3% CAGR vs -0.5%).
Domo, Inc. is an American cloud software company based in American Fork, Utah, United States. It specializes in artificial intelligence, business intelligence, and data visualization and is designed to provide real-time access to business data for decision makers across the company with minimal IT involvement. It is a Software-as-a-Service (SaaS) venture.
Xeris Biopharma Holdings, Inc. is a specialty biopharmaceutical company that develops and commercializes targeted therapies for rare endocrine, metabolic, and dermatological conditions. It operates across global markets, focusing on delivering accessible, easy-to-administer treatment options for underserved patient segments.
DOMO vs XERS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $79.4M | $85.8M |
| Net Profit | $-10.4M | $11.1M |
| Gross Margin | 74.2% | — |
| Operating Margin | -8.7% | 19.5% |
| Net Margin | -13.1% | 12.9% |
| Revenue YoY | -0.5% | 42.8% |
| Net Profit YoY | 44.6% | 316.7% |
| EPS (diluted) | $-0.25 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $79.4M | $85.8M | ||
| Q3 25 | $79.7M | $74.4M | ||
| Q2 25 | $80.1M | $71.5M | ||
| Q1 25 | $78.8M | $60.1M | ||
| Q4 24 | $79.8M | $60.1M | ||
| Q3 24 | $78.4M | $54.3M | ||
| Q2 24 | $80.1M | $48.1M | ||
| Q1 24 | $80.2M | $40.6M |
| Q4 25 | $-10.4M | $11.1M | ||
| Q3 25 | $-22.9M | $621.0K | ||
| Q2 25 | $-18.1M | $-1.9M | ||
| Q1 25 | $-17.7M | $-9.2M | ||
| Q4 24 | $-18.8M | $-5.1M | ||
| Q3 24 | $-19.5M | $-15.7M | ||
| Q2 24 | $-26.0M | $-15.0M | ||
| Q1 24 | $-18.7M | $-19.0M |
| Q4 25 | 74.2% | — | ||
| Q3 25 | 74.8% | — | ||
| Q2 25 | 74.2% | — | ||
| Q1 25 | 74.4% | — | ||
| Q4 24 | 75.0% | — | ||
| Q3 24 | 74.3% | — | ||
| Q2 24 | 74.1% | — | ||
| Q1 24 | 76.3% | — |
| Q4 25 | -8.7% | 19.5% | ||
| Q3 25 | -9.1% | 9.0% | ||
| Q2 25 | -17.9% | 6.3% | ||
| Q1 25 | -15.6% | -5.1% | ||
| Q4 24 | -13.9% | 2.8% | ||
| Q3 24 | -18.5% | -23.8% | ||
| Q2 24 | -26.8% | -17.0% | ||
| Q1 24 | -16.6% | -35.1% |
| Q4 25 | -13.1% | 12.9% | ||
| Q3 25 | -28.8% | 0.8% | ||
| Q2 25 | -22.5% | -2.7% | ||
| Q1 25 | -22.4% | -15.3% | ||
| Q4 24 | -23.5% | -8.5% | ||
| Q3 24 | -24.9% | -29.0% | ||
| Q2 24 | -32.5% | -31.2% | ||
| Q1 24 | -23.3% | -46.7% |
| Q4 25 | $-0.25 | $0.07 | ||
| Q3 25 | $-0.56 | $0.00 | ||
| Q2 25 | $-0.45 | $-0.01 | ||
| Q1 25 | $-0.45 | $-0.06 | ||
| Q4 24 | $-0.48 | $-0.02 | ||
| Q3 24 | $-0.51 | $-0.11 | ||
| Q2 24 | $-0.69 | $-0.10 | ||
| Q1 24 | $-0.51 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $111.0M |
| Total DebtLower is stronger | $124.2M | $220.3M |
| Stockholders' EquityBook value | $-191.9M | $13.7M |
| Total Assets | $201.6M | $383.5M |
| Debt / EquityLower = less leverage | — | 16.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $111.0M | ||
| Q3 25 | — | $91.6M | ||
| Q2 25 | $47.2M | $59.3M | ||
| Q1 25 | $45.3M | $58.4M | ||
| Q4 24 | — | $71.6M | ||
| Q3 24 | — | $69.4M | ||
| Q2 24 | $61.2M | $77.6M | ||
| Q1 24 | $60.9M | $87.4M |
| Q4 25 | $124.2M | $220.3M | ||
| Q3 25 | $121.9M | $219.5M | ||
| Q2 25 | $119.7M | $218.6M | ||
| Q1 25 | $117.7M | $229.8M | ||
| Q4 24 | $115.6M | $232.1M | ||
| Q3 24 | $115.2M | $216.2M | ||
| Q2 24 | $114.1M | $230.5M | ||
| Q1 24 | $113.5M | $229.7M |
| Q4 25 | $-191.9M | $13.7M | ||
| Q3 25 | $-191.5M | $-861.0K | ||
| Q2 25 | $-178.7M | $-19.3M | ||
| Q1 25 | $-177.2M | $-35.1M | ||
| Q4 24 | $-171.2M | $-29.6M | ||
| Q3 24 | $-166.4M | $-28.3M | ||
| Q2 24 | $-163.5M | $-19.3M | ||
| Q1 24 | $-153.5M | $-9.2M |
| Q4 25 | $201.6M | $383.5M | ||
| Q3 25 | $195.7M | $370.2M | ||
| Q2 25 | $189.7M | $334.7M | ||
| Q1 25 | $214.3M | $315.5M | ||
| Q4 24 | $190.2M | $323.1M | ||
| Q3 24 | $197.8M | $321.1M | ||
| Q2 24 | $204.4M | $331.7M | ||
| Q1 24 | $225.7M | $336.6M |
| Q4 25 | — | 16.10× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $3.4M | $20.0M |
| Free Cash FlowOCF − Capex | $1.1M | — |
| FCF MarginFCF / Revenue | 1.4% | — |
| Capex IntensityCapex / Revenue | 2.9% | — |
| Cash ConversionOCF / Net Profit | — | 1.81× |
| TTM Free Cash FlowTrailing 4 quarters | $9.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $3.4M | $20.0M | ||
| Q3 25 | $3.4M | $18.4M | ||
| Q2 25 | $4.0M | $182.0K | ||
| Q1 25 | $8.9M | $-10.0M | ||
| Q4 24 | $-13.7M | $2.0M | ||
| Q3 24 | $-6.2M | $-8.3M | ||
| Q2 24 | $1.9M | $-10.3M | ||
| Q1 24 | $5.4M | $-20.3M |
| Q4 25 | $1.1M | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $1.0M | — | ||
| Q1 25 | $6.7M | — | ||
| Q4 24 | $-16.2M | — | ||
| Q3 24 | $-8.4M | — | ||
| Q2 24 | $-625.0K | — | ||
| Q1 24 | $2.9M | — |
| Q4 25 | 1.4% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.3% | — | ||
| Q1 25 | 8.5% | — | ||
| Q4 24 | -20.3% | — | ||
| Q3 24 | -10.7% | — | ||
| Q2 24 | -0.8% | — | ||
| Q1 24 | 3.6% | — |
| Q4 25 | 2.9% | — | ||
| Q3 25 | 2.9% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 2.8% | — | ||
| Q4 24 | 3.2% | — | ||
| Q3 24 | 2.8% | — | ||
| Q2 24 | 3.2% | — | ||
| Q1 24 | 3.1% | — |
| Q4 25 | — | 1.81× | ||
| Q3 25 | — | 29.68× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
XERS
| Products | $83.4M | 97% |
| Other | $2.4M | 3% |
